Two cutting-edge artificial intelligence tools used to assist the diagnosis of strokes have been approved by the National Institute for Health and Care Excellence (NICE). The team of national experts, which includes researchers ...
Mar 4, 2024
0
0
More than 80% of stroke survivors experience walking difficulty, significantly impacting their daily lives, independence, and overall quality of life. Now, new research from the University of Massachusetts Amherst pushes ...
Mar 4, 2024
0
6
A drug being developed by scientists at The University of Toledo could one day help stroke survivors return to the lives they previously enjoyed.
Mar 1, 2024
0
0
People with type 2 diabetes have an increased risk of stroke and a worsened outcome after suffering from it. Now, researchers at the Karolinska Institutet have shown that stroke outcome is significantly improved in mice with ...
Mar 1, 2024
0
24
Hourly heat exposure is associated with an increased risk for acute ischemic stroke (AIS) onset, according to a study published online Feb. 28 in JAMA Network Open.
Feb 29, 2024
0
0
For people with stroke, social factors such as education, neighborhood and employment may be linked to whether they receive treatment with clot-busting drug, according to a preliminary study that will be presented at the ...
Feb 28, 2024
0
0
A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been ...
Feb 28, 2024
0
1
Every year, more than 100 million people worldwide suffer a stroke. Ischemic strokes (cerebral infarction) are the most common, but they can also occur silently and therefore often go undetected. This can result in serious ...
Feb 27, 2024
0
1
Heart disease researchers have identified a group of patients for whom international guidelines on aspirin use for heart health may not apply.
Feb 27, 2024
0
1
A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has successfully developed a neutralizing monoclonal antibody, 6H2, which targets a harmful protein known to exacerbate damage caused ...
Feb 27, 2024
0
0
